'IV Cocktail' Ads Stir FTC To Prioritize Health Enforcement
The Federal Trade Commission last week required a company to stop marketing its intravenous therapy "cocktails" as a treatment for serious diseases without scientific proof, a first-of-its-kind action that signals the...To view the full article, register now.
Already a subscriber? Click here to view full article